Clinical outcome in AML correlates with LSC-associated miRNA expression
miR-126 targets multiple components of the PI3K/AKT/MTOR signaling pathway
miR-126 promotes chemotherapy resistance by preserving LSC in a quiescent state
miR-126 governs opposing self-renewal outcomes in normal and malignant stem cells